MX2022011901A - Arilo piperidinas como moduladores de monoacilglicerol lipasa. - Google Patents
Arilo piperidinas como moduladores de monoacilglicerol lipasa.Info
- Publication number
- MX2022011901A MX2022011901A MX2022011901A MX2022011901A MX2022011901A MX 2022011901 A MX2022011901 A MX 2022011901A MX 2022011901 A MX2022011901 A MX 2022011901A MX 2022011901 A MX2022011901 A MX 2022011901A MX 2022011901 A MX2022011901 A MX 2022011901A
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- disorders
- monoacylglycerol lipase
- methods
- aryl piperidines
- Prior art date
Links
- -1 Aryl piperidines Chemical class 0.000 title abstract 3
- 102000005398 Monoacylglycerol Lipase Human genes 0.000 title 1
- 108020002334 Monoacylglycerol lipase Proteins 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000036640 Asperger disease Diseases 0.000 abstract 1
- 201000006062 Asperger syndrome Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000028552 Treatment-Resistant Depressive disease Diseases 0.000 abstract 1
- 208000029560 autism spectrum disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000024714 major depressive disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Compuestos de arilo piperidina de la Fórmula (I), y sales, isótopos, N-óxidos, solvatos, y estereoisómeros farmacéuticamente aceptables de estos, composiciones farmacéuticas que los contienen, y métodos para usarlos que incluyen métodos para tratar estados de enfermedad, trastornos y afecciones asociados con la modulación de la MGL, tales como aquellos asociados con dolor, trastornos psiquiátricos, trastornos neurológicos (que incluyen, pero no se limitan a, trastorno depresivo mayor, depresión resistente al tratamiento, depresión ansiosa, trastornos del espectro autista, síndrome de Asperger, trastorno bipolar), cánceres y afecciones oculares: (ver fórmula); en donde X, R2a, R2b, R3, R4, R5a y R5b, se definen en la presente descripción.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063000282P | 2020-03-26 | 2020-03-26 | |
PCT/EP2021/057820 WO2021191384A1 (en) | 2020-03-26 | 2021-03-25 | Aryl piperidines as monoacylglycerol lipase modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022011901A true MX2022011901A (es) | 2023-01-04 |
Family
ID=75302569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022011901A MX2022011901A (es) | 2020-03-26 | 2021-03-25 | Arilo piperidinas como moduladores de monoacilglicerol lipasa. |
Country Status (10)
Country | Link |
---|---|
US (2) | US11787798B2 (es) |
EP (1) | EP4126840A1 (es) |
JP (1) | JP2023518515A (es) |
KR (1) | KR20220158060A (es) |
CN (1) | CN115362151A (es) |
AU (1) | AU2021243726A1 (es) |
BR (1) | BR112022019155A2 (es) |
CA (1) | CA3177058A1 (es) |
MX (1) | MX2022011901A (es) |
WO (1) | WO2021191384A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL295447A (en) | 2020-02-10 | 2022-10-01 | Janssen Pharmaceutica Nv | Monoacylglycerol lipase modulators |
WO2021191384A1 (en) | 2020-03-26 | 2021-09-30 | Janssen Pharmaceutica Nv | Aryl piperidines as monoacylglycerol lipase modulators |
CN115362153A (zh) | 2020-03-26 | 2022-11-18 | 詹森药业有限公司 | 作为单酰基甘油脂肪酶调节剂的氮杂螺环 |
JP2023518556A (ja) | 2020-03-26 | 2023-05-02 | ヤンセン ファーマシューティカ エヌ.ベー. | モノアシルグリセロールリパーゼ調節因子としてのアミノシクロブタン |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060135508A1 (en) | 2002-07-25 | 2006-06-22 | Manuela Villa | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
EP2090576A1 (en) | 2008-02-01 | 2009-08-19 | Merz Pharma GmbH & Co.KGaA | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
US8415341B2 (en) * | 2009-04-22 | 2013-04-09 | Janssen Pharmaceutica, Nv | Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
MX2014003879A (es) | 2011-09-30 | 2014-09-01 | Janssen Pharmaceutica Nv | Inhibidores de monoacilglicerol lipasa para el tratamiento de enfermedades metabolicas y trastornos relacionados. |
US10323026B2 (en) * | 2016-03-31 | 2019-06-18 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
WO2017170830A1 (ja) * | 2016-03-31 | 2017-10-05 | 武田薬品工業株式会社 | 複素環化合物 |
JP7189143B2 (ja) | 2017-09-29 | 2022-12-13 | 武田薬品工業株式会社 | 複素環化合物 |
CN112272670B (zh) | 2019-04-16 | 2023-12-12 | 上海翰森生物医药科技有限公司 | 含二并环类衍生物抑制剂、其制备方法和应用 |
IL295447A (en) | 2020-02-10 | 2022-10-01 | Janssen Pharmaceutica Nv | Monoacylglycerol lipase modulators |
WO2021191384A1 (en) | 2020-03-26 | 2021-09-30 | Janssen Pharmaceutica Nv | Aryl piperidines as monoacylglycerol lipase modulators |
CN115362153A (zh) | 2020-03-26 | 2022-11-18 | 詹森药业有限公司 | 作为单酰基甘油脂肪酶调节剂的氮杂螺环 |
JP2023518556A (ja) | 2020-03-26 | 2023-05-02 | ヤンセン ファーマシューティカ エヌ.ベー. | モノアシルグリセロールリパーゼ調節因子としてのアミノシクロブタン |
-
2021
- 2021-03-25 WO PCT/EP2021/057820 patent/WO2021191384A1/en unknown
- 2021-03-25 EP EP21715555.5A patent/EP4126840A1/en active Pending
- 2021-03-25 CA CA3177058A patent/CA3177058A1/en active Pending
- 2021-03-25 JP JP2022557701A patent/JP2023518515A/ja active Pending
- 2021-03-25 MX MX2022011901A patent/MX2022011901A/es unknown
- 2021-03-25 US US17/212,274 patent/US11787798B2/en active Active
- 2021-03-25 BR BR112022019155A patent/BR112022019155A2/pt unknown
- 2021-03-25 KR KR1020227037060A patent/KR20220158060A/ko unknown
- 2021-03-25 CN CN202180024366.0A patent/CN115362151A/zh active Pending
- 2021-03-25 AU AU2021243726A patent/AU2021243726A1/en active Pending
-
2023
- 2023-09-21 US US18/472,101 patent/US20240092781A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2021243726A1 (en) | 2022-09-29 |
JP2023518515A (ja) | 2023-05-01 |
US20240092781A1 (en) | 2024-03-21 |
BR112022019155A2 (pt) | 2022-12-06 |
KR20220158060A (ko) | 2022-11-29 |
CN115362151A (zh) | 2022-11-18 |
US11787798B2 (en) | 2023-10-17 |
WO2021191384A1 (en) | 2021-09-30 |
EP4126840A1 (en) | 2023-02-08 |
US20220363679A1 (en) | 2022-11-17 |
CA3177058A1 (en) | 2021-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022011901A (es) | Arilo piperidinas como moduladores de monoacilglicerol lipasa. | |
MX2022011904A (es) | Aminociclobutanos como moduladores de monoacilglicerol lipasa. | |
MX2022011903A (es) | Azaspirociclos como moduladores de monoacilglicerol lipasa. | |
MX2022011902A (es) | Moduladores de la monoacilglicerol lipasa. | |
MX2022009804A (es) | Moduladores de la monoacilglicerol lipasa. | |
CR20210153A (es) | Moduladores de monoacilglicerol lipasa | |
MX2021003661A (es) | Moduladores de la monoacilglicerol lipasa. | |
EP3097090B1 (en) | N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders | |
EP3310775A1 (en) | 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones | |
NZ512526A (en) | 4-sulfonamido-6-sulfamidoalkoxypyrimidine derivatives, pharmaceuticals thereof, and their use for the treatment of disorders associated with a role of endothelin. | |
MX2023003240A (es) | Moduladores de monoacilglicerol lipasa de ciclobutilamida. | |
RU94039284A (ru) | Производные пиперазина, способ их получения, фармкомпозиция и ее использование | |
MX2023009285A (es) | Compuestos novedosos. | |
US7741343B2 (en) | 6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands | |
EA201992127A1 (ru) | ФАРМАКОЛОГИЧЕСКИ АКТИВНЫЕ АЛИЦИКЛИЧЕСКИ ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНА | |
KR20030053475A (ko) | 5-ht3 및 신경세포의 니코틴작용성 수용체 길항물질로서의 1-아미노-알킬시클로헥산 화합물을 이용한 치료방법 및 이 화합물을 함유하는 약학적 조성물 | |
MX2023003165A (es) | Moduladores de la caseína cinasa 1 delta. | |
EP2842942B1 (en) | Trans-2-decenoic acid derivative and drug containing same | |
US20200392126A1 (en) | Isoxazolyl compounds as receptor modulating compounds and methods and uses thereof | |
MX2023003170A (es) | Moduladores de la caseina cinasa 1 delta. | |
KR890006653A (ko) | 헤테로사이클릭 화합물 및 이의 제조방법 및 용도 | |
WO2023115060A1 (en) | Psychoplastogens for treating hearing-related disorders |